| API SYNTHESIS AND MANUFACTURING |
Cynthia A. Challener
For many processes involving hazardous chemistry, running in flow mode has safety and economic advantages.
/ read more /
| LYOPHILIZATION |
Agnes Shanley
A technology roadmap aims to drive and consolidate improvements in a process that has remained unchanged for more than 70 years.
/ read more /
| PEER-REVIEWED |
Máté Mihalovits, Sándor Kemény
In Part I of this article series, the authors discussed the regression control chart method for identifying out-of-trend data in pharmaceutical stability studies. In Part II, the by-time-point method and the multivariate control chart method are investigated, and improved approaches are suggested. The method is illustrated using real data sets.
/ read more /
| FACILITY DESIGN AND OPERATIONS |
Jennifer Markarian
Optimizing water and HVAC systems can reduce resource use in all pharma facilities, and, for biopharma manufacturing, the supply chain of consumables should be evaluated.
/ read more /
| GOOD DISTRIBUTION PRACTICES |
Ian Elliot
Cross-functional reliability rooms identify risk and planning metrics, provide insights for production forecasts, and predict trends and areas for improvement.
/ read more /
| EUROPEAN REGULATORY WATCH |
Sean Milmo
The European Commission's effort to relax supplementary protection certificates to help generic-drug makers and biosimilars producers has sparked strong opposition from the research-based pharmaceutical sector.
/ read more /
| OUTSOURCING REVIEW |
Susan Haigney
In a productive year, 2017 was filled with acquisitions, facility expansions, and new biopharma technology.
/ read more /
| ASK THE EXPERT |
Susan J. Schniepp
SOPs need to reflect a company's specific manufacturing or other operations, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
/ read more /
|
